Thursday, February 02, 2023 6:09:03 AM
As suspected and yet again, the info being posted about naked shorting is misinformation. By their own admission, FINRA does not track naked shorting.
The continued attempt to mislead is not surprising
https://www.finra.org/investors/insights/short-interest
The continued attempt to mislead is not surprising
https://www.finra.org/investors/insights/short-interest
Bearish
FACTS are stubborn things
Recent RGBP News
- Regen BioPharma Update on Orphan Drug Application for HemaXellerate Will Be Presented At Emerging Growth Conference on September 24, 2025 • GlobeNewswire Inc. • 09/23/2025 12:00:00 PM
- Regen BioPharma Prepares Response For FDA Regarding Its Orphan Drug Application for HemaXellerate • GlobeNewswire Inc. • 09/16/2025 12:00:00 PM
